CAS 853400-76-7
:Acide L-glutamique, glycyl-2-méthyl-L-prolyl-
- Trofinetide(NNZ2566)
- Trofinetide
- TROFINETIDE; NNZ2566 ;NNZ 2566; NNZ-2566
- NNZ-2566
- L-Glutamic acid, glycyl-2-methyl-L-prolyl-
- Trofinetide,NNZ 2566,NNZ2566,Inhibitor,inhibit
Glycyl-2-methyl-L-prolyl-L-glutamic acid
CAS :Formule :C13H21N3O6Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :315.3223Trofinetide
CAS :Trofinetide (NNZ-2566) is a synthetic analog of the endogenous N-terminus tripeptide. It has been shown to be neuroprotective in animal models of brain injury.Formule :C13H21N3O6Degré de pureté :98.70% - 99.50%Couleur et forme :SolidMasse moléculaire :315.32Trofinetide (>90%)
CAS :Produit contrôléApplications Trofinetide is a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), that has shown to be neuroprotective in animal models of brain injury.
References Wei, H.H. et al.: J Neuroinflammation. 2009 Aug 5;6:19.Formule :C13H21N3O6Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :315.32Trofinetide
CAS :Trofinetide is a neuroprotective compound that acts as an antioxidant. Trofinetide has been shown to reduce oxidative stress and protect against neuronal death in cells. It also has been shown to improve the clinical response in patients with Alzheimer's disease, and may be used for the treatment of other neurodegenerative disorders such as Parkinson's disease. Trofinetide is orally administered and is metabolized by cytochrome P450 enzymes, which makes it a suitable candidate for specific treatments. The pharmacokinetic properties of trofinetide are not well understood due to its short half-life.
Formule :C13H21N3O6Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :315.32 g/molRef: 3D-DJB40076
Produit arrêté





